White, A C <br/><br/>
Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Aug 1997 
 - 230-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1086/514545  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acinetobacter--drug effects<br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--administration & dosage<br/>Bacteremia--diagnosis<br/>Communicable Disease Control<br/>Community-Acquired Infections--drug therapy<br/>Cross Infection--drug therapy<br/>Drug Resistance, Microbial<br/>Enterobacter cloacae--drug effects<br/>Escherichia coli--drug effects<br/>Female<br/>Gram-Negative Bacteria--drug effects<br/>Gram-Negative Bacterial Infections--drug therapy<br/>Hospitals, Urban--economics<br/>Humans<br/>Intensive Care Units<br/>Klebsiella pneumoniae--drug effects<br/>Male<br/>Medication Systems, Hospital--economics<br/>Middle Aged<br/>Outpatients<br/>Pseudomonas aeruginosa--drug effects<br/>Risk Factors<br/>Treatment Outcome